NasdaqCM - Nasdaq Real Time Price USD
NRx Pharmaceuticals, Inc. (NRXP)
2.6200
-0.0700
(-2.60%)
At close: May 23 at 4:00:01 PM EDT
2.5700
-0.05
(-1.91%)
After hours: May 23 at 7:50:41 PM EDT
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 1 | 1 | 1 | 1 |
| Avg. Estimate | -0.31 | -0.36 | -0.4 | 0.5 |
| Low Estimate | -0.31 | -0.36 | -0.4 | 0.5 |
| High Estimate | -0.31 | -0.36 | -0.4 | 0.5 |
| Year Ago EPS | -0.75 | -0.15 | -2.36 | -0.4 |
Revenue Estimate
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 1 | 1 | 2 | 3 |
| Avg. Estimate | -- | 13.5M | 68.6M | 107.58M |
| Low Estimate | -- | 13.5M | 30M | 42.43M |
| High Estimate | -- | 13.5M | 107.2M | 180.3M |
| Year Ago Sales | -- | -- | -- | 68.6M |
| Sales Growth (year/est) | 0.00% | 0.00% | 0.00% | 56.82% |
Earnings History
| Currency in USD | 6/30/2024 | 9/30/2024 | 12/31/2024 | 3/31/2025 |
|---|---|---|---|---|
| EPS Est. | -0.69 | -0.66 | -0.37 | -0.25 |
| EPS Actual | -0.75 | -0.15 | -0.77 | -0.34 |
| Difference | -0.06 | 0.51 | -0.4 | -0.09 |
| Surprise % | -7.91% | 77.27% | -108.11% | -36.00% |
EPS Trend
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Current Estimate | -0.31 | -0.36 | -0.4 | 0.5 |
| 7 Days Ago | -0.22 | 0.25 | -0.23 | 0 |
| 30 Days Ago | -0.22 | 0.25 | -0.06 | 0 |
| 60 Days Ago | -0.22 | 0.25 | -0.06 | 0 |
| 90 Days Ago | -0.22 | 0.25 | -0.03 | 0 |
EPS Revisions
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | -- |
| Up Last 30 Days | -- | -- | -- | -- |
| Down Last 7 Days | 1 | 1 | -- | -- |
| Down Last 30 Days | 1 | 1 | -- | -- |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| NRXP | 58.67% | -140.00% | 83.05% | 225.00% |
| S&P 500 | 12.65% | 2.49% | 7.39% | 14.05% |
Upgrades & Downgrades
| Maintains | D. Boral Capital: Buy to Buy | 5/16/2025 |
| Maintains | D. Boral Capital: Buy to Buy | 4/30/2025 |
| Maintains | Ascendiant Capital: Buy to Buy | 4/29/2025 |
| Initiated | BTIG: Buy | 4/2/2025 |
| Maintains | D. Boral Capital: Buy to Buy | 3/31/2025 |
| Maintains | D. Boral Capital: Buy to Buy | 3/24/2025 |
Related Tickers
NNVC NanoViricides, Inc.
1.7900
+20.95%
GTBP GT Biopharma, Inc.
2.8900
+8.24%
RLFTF Relief Therapeutics Holding SA
3.6100
-4.50%
BDRX Biodexa Pharmaceuticals Plc
1.1500
-17.27%
EYEN Eyenovia, Inc.
1.7700
-12.81%
NRXS NeurAxis, Inc.
3.0300
0.00%
PBM Psyence Biomedical Ltd.
4.3900
-0.68%
NLSP NLS Pharmaceutics AG
1.8500
-5.13%
ARMP Armata Pharmaceuticals, Inc.
1.8900
+1.07%
ABP Abpro Corporation
0.2120
-7.83%